30361
document
Effects of electro-acupuncture on T cell subpopulations , NK activity , humoral immunity and leukocyte count in patients undergoing chemotherapy . OBJECTIVE To observe the effects of electro-acupuncture on T cell subpopulations , natural killer cell ( NK ) activity , humoral immunity and leukocyte count in patients undergoing chemotherapy . METHODS Electro-acupuncture was added for patients undergoing chemotherapy . Tests were done on T cell subpopulations , NK activity , humoral immunity and leukocyte count before treatment and after 4 courses of treatment . RESULTS After 4 courses of treatment with chemotherapy and electro-acupuncture , no obvious changes were found in T cell subpopulations , NK activity , humoral immunity and leukocyte count ( P > 0.05 ) as compared with those before treatment . Patients undergoing chemotherapy combined with electro-acupuncture showed obviously higher leukocyte count than that of the control group given no leukogenic drugs ( P < 0.01 ) . CONCLUSION Electro-acupuncture may reduce immunologic damage caused by chemotherapy , thus it can be used as the auxiliary therapy for patients undergoing chemotherapy .
30362
Intervention_Physical
electro-acupuncture
30363
Intervention_Physical
electro-acupuncture
30364
Intervention_Pharmacological
chemotherapy
30365
Intervention_Physical
Electro-acupuncture
30366
Intervention_Pharmacological
chemotherapy
30367
Intervention_Pharmacological
chemotherapy
30368
Intervention_Physical
electro-acupuncture
30369
Intervention_Pharmacological
chemotherapy
30370
Intervention_Physical
electro-acupuncture
30371
Intervention_Physical
Electro-acupuncture
30372
Intervention_Pharmacological
chemotherapy
30373
Intervention_Pharmacological
chemotherapy
30374
Outcome_Physical
T cell subpopulations , NK activity , humoral immunity and leukocyte count
30375
Outcome_Physical
T cell subpopulations
30376
Outcome_Physical
natural killer cell ( NK ) activity
30377
Outcome_Physical
humoral immunity
30378
Outcome_Physical
leukocyte count
30379
Outcome_Physical
T cell subpopulations
30380
Outcome_Physical
NK activity
30381
Outcome_Physical
humoral immunity
30382
Outcome_Physical
leukocyte count
30383
Outcome_Physical
changes
30384
Outcome_Physical
T cell subpopulations
30385
Outcome_Physical
NK activity
30386
Outcome_Physical
humoral immunity
30387
Outcome_Physical
leukocyte count
30388
Outcome_Physical
leukocyte count
30389
Outcome_Physical
immunologic damage
30390
Participant_Condition
chemotherapy
30391
Participant_Condition
chemotherapy
30392
Participant_Condition
chemotherapy
30393
Participant_Condition
chemotherapy